Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc16-1347
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2558145946
